Thrivent Financial for Lutherans Cuts Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Thrivent Financial for Lutherans cut its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 3.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,800 shares of the company’s stock after selling 1,003 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Ryan Specialty were worth $1,846,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of RYAN. Hollencrest Capital Management bought a new stake in Ryan Specialty during the third quarter valued at approximately $25,000. Assetmark Inc. bought a new stake in shares of Ryan Specialty during the 3rd quarter worth approximately $34,000. GAMMA Investing LLC lifted its holdings in shares of Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after buying an additional 297 shares during the period. Crewe Advisors LLC purchased a new stake in shares of Ryan Specialty during the 2nd quarter worth $39,000. Finally, Rothschild Investment LLC purchased a new stake in Ryan Specialty in the second quarter valued at about $87,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 0.0 %

Ryan Specialty stock opened at $75.09 on Friday. Ryan Specialty Holdings, Inc. has a 1 year low of $41.49 and a 1 year high of $75.86. The firm’s 50-day moving average is $69.74 and its 200-day moving average is $63.04. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $19.66 billion, a P/E ratio of 97.52, a PEG ratio of 1.69 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the previous year, the firm posted $0.32 EPS. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. On average, equities analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.59%. Ryan Specialty’s dividend payout ratio (DPR) is currently 57.14%.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

RYAN has been the subject of several recent analyst reports. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. JPMorgan Chase & Co. boosted their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. The Goldman Sachs Group upped their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. Bank of America boosted their target price on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Finally, UBS Group increased their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a report on Tuesday, August 13th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $71.67.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.